Planet 13 Doubles Dispensary Floor Square Footage and Cash Registers at Las Vegas SuperStore
LAS VEGAS, NV / ACCESSWIRE / September 21, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
News
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
An Internationally Recognized Authority in Dry Eye Disease, Dr. Tauber has Participated in over 140 Research Studies as Principal Investigator...
Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360
SAN DIEGO, CA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...
The Jericho Center of Medical Diplomacy Presents at 2021 C3 US-Arab Healthcare and Business Summit
New York, NY, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The C3 Summit is a renowned gathering that fosters US-Arab Healthcare...
Immutep to Present Final Overall Survival Data From Phase IIb AIPAC as a Late Breaking Poster Presentation at SITC 2021
SYDNEY, Australia, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Evaxion Biotech Appoints Dr. Birgitte Rønø as Chief Scientific Officer
Dr. Rønø has developed Evaxion's pre-clinical and early clinical oncology pipelineNewly-created Chief Scientific Officer role strengthens Evaxion's leadership teamCOPENHAGEN, Denmark,...
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing...
Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel,...
Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multiple Novel Therapies in Neuroscience
33 early and late-stage clinical programs across modalities and innovative discovery platformsUniquely positioned to lead in Alzheimer’s disease with ADUHELM®...
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
LifeSci Partners Announces Strategic Partnership with Expert Network, FirstThought
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeSci Partners, a life-sciences focused consultancy, today announced that it has entered...
New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device ManufacturersMALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE)...
Outlook Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
Live fireside chat with C. Russell Trenary, President and CEO of Outlook Therapeutics on Tuesday, September 28 at 2:00 PM...
Amolyt Pharma to Present Phase 1 Clinical Trial Data for Lead Product Candidate AZP-3601 at the American Society for Bone and Mineral Research 2021 Annual Meeting
Company will also host key opinion leader webinar on Friday, October 1 at 10:00am ET, to discuss Phase 1 healthy...
LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) a rapidly growing direct-to-patient telehealth company that...
COMPASS Pathways to participate in upcoming Maxim and Cantor investor conferences
London, UK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to...
Intercept to Present at the 2021 Cantor Virtual Global Healthcare Conference
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization...
Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
Patents Further Strengthen and Enhance Intellectual Property (IP) PortfolioCAMBRIDGE, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ:...
Selecta Biosciences to Participate in Cantor Virtual Global Healthcare Conference
WATERTOWN, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Longeveron Announces Dr. Jorge Ruiz as Speaker for Roundtable Discussion & Presentation at 2021 International Conference for Frailty & Sarcopenia Research
-- Jorge Ruiz, M.D., Associate Director for Clinical Affairs, Geriatric Research at the Miami VA Healthcare System, will present Longeveron’s...